Free Guest Blogs Posting For Health and Fitness

Malaria Treatment Market Insight by Trends, Opportunities, and Competitive Analysis

Malaria is a prevalent disease, specifically during monsoons. If not treated for a specific duration, it might cause death. The disease is spread through the bite of the mosquito, which is already infected by tiny parasites. When such mosquito bites, it injects the parasite causing disease into the bloodstream.

If left untreated, the disease can adversely impact health causing seizures, trouble breathing, brain damage, organ failure, and death.

If a mosquito bites a person with malaria, the mosquito gets the infection, and thereafter if it bites any other person, it transfers the malaria parasite into the bloodstream of that person, making him or her also infected. These parasites multiply in the bloodstream. Humans can be infected by five types of malaria parasites.

It is least likely to happen but has the possibility to pass the disease through organ donations, blood transfusions, and hypodermic needles.

The symptoms and signs of malaria flu include:
• Sweating and Fever
• Breathing problems, cough, and chest pain
• Vomiting, Nausea, and Diarrhoea

 

For Getting Sample Pages of This Report:-

https://www.psmarketresearch.com/market-analysis/malaria-treatment-market/report-sample

 

The healthcare provider examines the patient and asks about the symptoms and recent travel history. It is crucial to share such information, regarding the visit to any country recently to better understand the risk.

Several drugs are taken by combining them with other drugs. It depends upon the parasite what type of medication is needed and for how long should be taken.

Major Antimalarial Drugs
• Artemisinin drugs: They provide the best treatment for plasmodium falciparum malaria with artemisinin combination therapy.
• Atovaquone
• Chloroquine-Several parasites may show resistance to it.
• Doxycycline

The major pharmaceutical companies offering malarial treatment are Sun Pharmaceutical Industries Limited, Novartis AG, Mylan N.V., and Teva Pharmaceuticals Industries Ltd.

The growing prevalence of malaria boosts the demand for its treatment, more specifically in tropic regions with hot and humid weather.

Spread the love